Breast cancer is the second most common cancer type in the world and the most common cancer type in women. The number of newly diagnosed breast cancers in 2012 was 1.67 million, and breast cancer makes up 25% of all types of cancer in women (1). According to the data of the World Health Organization (WHO), the number of women who died of breast cancer worldwide in 2011 was 508 000. Breast cancer incidence increases as life expectancy increases, and urbanization and western lifestyles are adopted more and more in today's ever-developing world. It frequently occurs in both developed and less developed countries (2).
Social support is usually considered as the help provided for the individual who is under stress or in a difficult situation by people around the individual. The person receives support from their family or significant people in their life when they feel their abilities are inadequate or worn out. It has been reported that social support affects physical and emotional health positively by meeting fundamental social needs such as love, compassion, and belonging to a group, and is a significant help for the person in coping with difficulties in life (8) (9) (10) (11) (12) .
We aimed to investigate how patients with breast cancer who were treated in our Outpatient Chemotherapy Unit looked for treatment options and the level of perceived social support.
Material and Methods
The population of this study comprised patients with breast cancer in Turgut Özal Medical Center, the only center with extensive cancer treatment in the city center of Malatya.
The study sample was calculated as 195 using n = t 2 . p. q / d 2 , the formula that is used when the population is unknown. We planned to include 15% more patients in the questionnaire and reached 225 patients in total. However, 17 patients who did not want to participate in the survey and 8 patients who participated but had no patient folder from which information about stage of diagnosis could be obtained were excluded; a total of 200 patients were included in the study.
Questionnaire Form:
The questionnaire form consisted of three sections. The first section included questions regarding the patients' sociodemographic characteristics, the second section had questions regarding patients' ways of seeking treatment, and in the third section there was a Multidimensional Scale of Perceived Social Support (MSPSS), which was used to analyze the patients' level of social support.
Treatment-related Information Form:
The patients were asked to write down some dates about their diagnostic process in certain questions included in the second section of the questionnaire form. Similar studies in the literature were taken into consideration, and the time elapsed between these dates was limited to 3 months for patient-related latency and 2 weeks for system-related latency (13) (14) (15) (16) (17) . In the event that the time elapsed between the date when the first symptom of disease was recognized and the date of first applying to a healthcare organization was more than three months, this was evaluated as 'Patient was late.' When the elapsed time was less than three months, the evaluation was 'Patient was not late.' Furthermore, if the time was longer than two weeks between the date of applying to a healthcare organization for the first time and the date of the definitive diagnosis, 'System was late' was recorded in the evaluation. Similarly, if it was less than two weeks, 'System was not late' was put in the evaluation.
Multidimensional Scale of Perceived Social Support (MSPSS):
The scale measures the adequacy of social support from 3 sources in 3 subscales: family, friends, and a significant other, and consists of a total of 12 items. There are three subscales with 4 items for each subscale regarding the source of support. Each question was analyzed using a 7-point Likert-type scale. The validity and reliability study of multidimensional scale of perceived social support in Turkey was conducted by Eker et al. (18) in 1995.
The subscale score in the multidimensional scale of perceived social support was obtained by calculating the total of the scores for the four items in each subscale, and the total scale score was obtained by calculation the total of all subscale scores. A high score indicated a high perception of social support. The mean scores were used in the statistical evaluation because there was no breakpoint in the scale.
Statistical analysis
The data of this study were analyzed in a computer environment using the Statistical Package for the Social Sciences (SPSS) for Windows software Version 22.0 (IBM Corp., Armonk, New York, USA). Quantitative data are presented with mean±standard deviation and the qualitative data in the question forms are presented as numbers (n) and percentages (%). The data were analyzed using Pearson's Chi-square test. The one-sample Kolmogorov-Smirnov test was used to determine whether the data had normal distribution. Independent samples t-test, one-way analysis of variance and multiple comparison test were used for normally distributed data. The results were in a 95% confidence interval and p<0.05 was considered as the level of significance.
Ethics approval was obtained from İnonu University Malatya Clinical Research Ethics Committee (Research Protocol No: 2012/183). Faceto-face meetings were held with the patient. After the aim of this questionnaire was explained to the patients, verbal consent was obtained and the questionnaire was conducted. Information in the questionnaire form regarding diagnostic stage was filled in one by one from the patients' patient folders in the Medical Oncology Outpatient Clinic Archive Room after the questionnaire forms were completed.
Result
The mean age of 200 women included in the study was 51.16±1.10 years (median: 50, range, 28-76 years) with most aged 45 years or more.
As shown in Table 1 , the educational background of 60% of the women was of elementary school level, 78.5% were housewives and 80.5% were married. Eighty-seven percent of the women had children and 13% did not. When they were asked about where they lived, 77.5% answered 'city center.' As shown in Table 2 , 12.5% of the women stated that was a history of breast cancer among their first-degree relatives. The first symptom they noticed in themselves was a mass in breast/axilla (69.5%) for most, followed by pain in breast (13%). The question 'Did you use to perform breast self-exam (BSE) before the disease?' was answered with 'no' by 62.5%. While 72.5% of the women stated that they noticed the first symptom coincidentally, almost half (50.5%) remarked they went to a public hospital first. The tumor stage of 12% of the women was Stage I, 31.5% was Stage II, 43% was Stage III, and 13.5% was Stage IV. Sixty-six percent of the women were evaluated as 'Patient was not late' because it had been 3 months or less from the first symptom till the first time of visiting a healthcare organization, and 34% were evaluated as 'Patient was late'. Eighty-six percent of the women had attended a second hospital after their first visit to a healthcare organization; 50% of which were referred to another hospital and 36% made their own decisions. Of the second healthcare organizations, 53% were university hospitals. The time between the date of consulting a healthcare organization for the first time and the date of the definitive diagnosis was two weeks or less for 55% of the women; therefore, these were evaluated as 'System was not late'. The healthcare organizations where a definitive diagnosis was made were mostly (53%) university hospitals. Some 42.5% of the women first chose to go to a public hospital and then a university hospital during their diagnosis and treatment process. Regarding the treatments they received during this study, 60% were both surgical operation and chemotherapy.
There was no statistically significant difference between whether patients were late due to patient-or system-related reasons and variables such as age, place of residence, education, tumor stage, and the first noticed symptom (p>0.05) (Table 3) . However, the differences of delay because of patient-or system-related reasons in patients with a : Diagnosis that took longer than two weeks was marked as 'System was late,' diagnosis in two weeks or less was evaluated as 'System was not late' breast cancer history within first-degree relatives were statistically significant (p<0.05).
As shown in Table 4 that the women gave the highest score to the family support group among three subscale groups in multidimensional scale of perceived social support, followed by significant other support.
As shown in Table 5 , the support scores of the women who selected 'made us closer' for their relationship with their husbands during the disease process were higher than those of women who selected 'did not make a difference' and 'made us more distant.'
The difference between the groups was significant when the 'significant other' support scores of the answers "made us closer," "did not make a difference," and "made us more distant" to the question regarding the effect of the disease on the relationship with husbands were compared (F= 13.27; p=0.0001). As a result of the least significant difference (LSD) test performed with multiple comparisons to determine the group that caused the difference, we found a difference between the paired comparisons amongst all groups. The highest score was of the "made us closer" group, followed by the "did not make a difference" group.
Discussion and Conclusion
Studies that investigated the effects of socio-demographic characteristics of women with breast cancer on incidence and survival reported that socio-demographic characteristics affected an individual's knowledge of cancer symptoms and participation in screening programs. Breast cancer history in an immediate relative within family was assessed as a risk factor for breast cancer. The risk of developing breast cancer was twice as high in a woman with a mother or sister with breast cancer (19) . Of the women who participated in our study, 12.5% had : Diagnosis that took longer than two weeks was marked as 'System was late' and diagnosis in two weeks or less was evaluated as 'System was not late'.
*Breast cancer in immediate relatives. **Pain, swelling and breast discharge.
a first-degree relative with a breast cancer history. Avcı reported that 14.3% of the women in their study had a first-degree relative with a breast cancer history (20) , which was similar to the results in our study.
Of the patients who participated in our study, 69.5% stated that the first symptom they noticed was a mass in the breast/axilla; 13% had pain in the breast and 10.5% reported breast deformity and discharge as their first symptom (Table 2) . Özgün et al. (21) reported 77.8% of the patients in their study had a breast mass, 14.2% had mass and pain in the breast, 3.1% had pain, and 3.8% had breast deformity and discharge as their first symptom.
Although not an effective screening program, the Breast Self-Exam (BSE) method is a recommended practice that is significant in terms of creating awareness. The women in our study were asked whether they had done BSE before diagnosis and 37.5% expressed that they had (Table 2 ). Dündar et al. (22) reported that 40.9% of the women in their study had practiced BSE. In a study by Champion, 48.1% of the women had performed BSE. However, the rate of patients who practice BSE regularly ranges between 18-36% (23). Rızalar et al. (24) reported the rate of those who performed BSE regularly was between 10-24% in their study. In a study by Surdyka et al. (25) , the rate of those who performed BSE was 65.6% but the rate of performing it regularly was 14.2%. The low number of those who practice BSE regularly indicates that there are many factors that affect women's attitude and behaviors towards early diagnosis. Among the reasons reported in the literature are the individual's cultural beliefs, perception of health and disease, social support factors, knowledge of the disease, and risk perception, and belief toward the importance of early diagnosis (24).
The women's answers to questions regarding how they first recognized their disease provided insight to women's participation in screening programs. Seventy-two percent of the women who participated in our study stated that they noticed the first symptom by chance and 13% said that the symptom was recognized by a healthcare professional. On the other hand, 8.5% reported their mass recognition by selecting "consulting a hospital for a different symptom, participation in a screening program". In a study by Özdemir et al. (26), 80% of the benign or malignant lesions were noticed by the women. Although only 37.5% of the women in our study claimed to have performed BSE, 72.5% stated they noticed the mass accidentally by themselves (Table  2 ). This is explained by the fact that even when most of the women did not examine their breast tissue, they were aware of the breast tissues and noticed the mass whilst showering or dressing. However, masses found by chance were mostly large masses; therefore, regular screening methods would make it possible to detect smaller masses and symptoms that may indicate breast cancer (24) .
When analyzing the hospitals the patients chose to consult during the treatment process, the rate of patients who chose university hospitals as the second organization was 62% (19.5% chose a university hospital after a private hospital and 42.5% consulted a university hospital after a public hospital). Patients follow different paths to obtain a second or a third physician's opinion or to be examined by a well-known physician during the diagnostic process. The economic, geographic, and socio-cultural structure of the region where the study was conducted affected the patients' ways of seeking treatment. In a study by Shieh et al. (27) , 64.3% of the patients consulted one hospital and 28.1% consulted two hospitals before diagnosis. The authors found that those who consulted three hospitals were diagnosed 10 times later than those who only went to one hospital. The number of consulted hospitals is one of the factors that causes delay in diagnosis. It was also reported that in cases when the first healthcare organization had an extensive diagnosis and treatment center, the delay in diagnosis was much shorter (27) .
Delay in diagnosis and treatment causes low survival rates in most cancer cases. A metaanalysis regarding this subject demonstrated that there was a strong and precise relationship between the delays and low survival rates (28) .
Regarding the time elapsed between the first symptoms noticed by the women and their visit to a healthcare organization, 34% of the patients were evaluated as 'patient was late' in our study (Table 2) . Harirchi et al. (29) reported that 42% of the cases had 'patient was late' in their study. Özgün et al. (21) reported that 29% of the patients were marked with 'patient was late'. Reasons for patient-related delay include cultural taboos regarding cancer centers, fear of hospitals, not trusting physicians or healthcare organizations, and lack of knowledge in breast cancer symptoms and risk factors (14) . The higher rate of delayed patients in our study compared with the western regions can be explained by the fact that our study was conducted in Malatya, which is located in the east of Turkey, and the educational background, level of awareness, and cultural taboo levels of the women in this city are different compared with other parts of Turkey.
There was no significant difference found when the delay status of the patients and variables such as age, place of residence, education, tumor stage, and first symptom were compared (Table 3 ). In their multinational study, Jassem et al. (30) reported that the delay was shorter in women with an intermediate education level, in women who work, Min: minimum; max: maximum; SD: standard deviation *39 women were not included in this group because they were divorced, widowed or single.
and in women who live in big towns or cities. Shimaa et al. (14) found no relationship between the delay statuses of the patients and age, place of residence, and educational level in their study. However, there was a significant relationship between tumor stage and delay in patients (14) . Innos et al. (31) aimed to define factors that caused delay in patients with breast cancer and found a relationship between factors that affect delay such as age, education, and first symptom. Rauscher et al. (32) mentioned behavioral and pre-assessment-based delays. Behavioral delays and delays based on pre-assessment are defined as when the patient becomes aware of the disease after noticing the first symptom and consults a hospital for medical service. As a result, the socio-demographic variables (age, educational background, living in a city center, economic condition) in this study were reported to cause delay by affecting the patient's interpretation of the first symptom and decision to apply for medical service (32) .
One of the important reasons why there was no significant difference when we compared delay in the women and their educational background, place of residence, age, economic condition, first symptom, and tumor stage in our study was that the patients could not clearly remember the time between they first noticed the symptom and when they visited a healthcare organization, i.e. the memory factor. The fact that the patients were asked about the dates of retrospective periods in the chemotherapy unit where the questionnaire was conducted while they were being treated might have been a factor as to why they could not remember.
After their first to a healthcare organization, 44.5% of the women waited more than two weeks till they had a definitive diagnosis. There was no significant difference between the variables such as age, place of residence, education, tumor stage, first noticed symptom of the women with 'system was late' evaluation in this group (Table 3 ). In the study by Jassem et al., system-related delays were shorter for women with at least intermediate levels of education and women aged more than 60 years (30) . There was a significant relationship found between younger women who noticed a mass by themselves and system-related delays. Ruddy et al. found no statistical difference between tumor stage and system delays in their study (33) .
There was a statistically significant difference between the women with a family history of breast cancer and their system-related delays (Table  3) . Some studies in the literature reported that system-related delays were shorter for women with a family history of breast cancer (30, 32) . Studies support that women with a history of breast cancer in their immediate relatives are more informed about breast cancer and therefore visit a healthcare organization earlier (32) . Performing population-based screening programs, which are known to decrease breast cancer mortality with proven efficiency, are important for early-stage diagnosis of cancer. Poor attendance in screening programs can be considered one of the factors in system-related delays. Despite the free-of-charge national screening programs in Turkey, the attendance remains low (34) .
Individuals who provide care for patients with cancer other than healthcare personnel create the social support network of the cancer patient (35, 36) . Although the mean family support score was the highest compared with other groups, there was no statistical difference in the subscale scores of social support in our study (Table 4 ). In a study by Dedeli et al. (35) on patients with cancer regarding sources of social support, it was discovered that a large part of social support comprised family support. A reason for why this group had the highest support score might be because family members of women (e.g. mother, sister) help more with the hospital procedures, household chores, and looking after children required during the disease or treatment process. Another reason is that women's fears and anxieties regarding relationship breakdowns and emotional distance in their marriage related to body image problems caused by mastectomy and chemotherapy, sexual dysfunction due to treatment, and changes in communication and social roles influence their communication negatively. Husbands' fear of losing their significant other may affect this support negatively (36) . In a similar study with patients with gynecologic cancers by Ayaz et al. (8) , family took first place as the subgroup of social support sources. Bertero et al. (37) determined that family had the highest rate compared with significant other and friend support within social support sources in their study. The findings in our study share similarities with the literature.
Clinical experience and studies demonstrated that some couples faced with cancer expressed that their relationships had improved since the beginning of the disease. Forty-two percent of patients stated the disease made them closer. These patients had higher scores in significant other support (38, 39) . Similar results were obtained in our study, and there was a significant relationship between the women who answered with 'made us closer' and their scores of significant other support. Those who stated their relationships improved since the disease had higher scores of significant other support (Table 5 ). In a study by Özbaş (40) , it was reported that strong marriages before the disease were stronger with the disease and that marriages that had been fundamentally weak before the disease were negatively affected in a short time.
Our study can have an indicative effect in terms of conducting studies in different parts of Turkey; therefore, comparisons between regions can be made and areas that should be focused on can be determined. Effective solutions can be produced with regard to time and cost for policymakers and managers. Informed Consent: Written informed consent was obtained from patients who participated in this study.
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